Intended for healthcare professionals

  1. Research
  2. Polygenic hazard score...
  3. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
CCBYNC Open access
Research

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.j5757 (Published 10 January 2018) Cite this as: BMJ 2018;360:j5757

Data supplement

  • Web Extra

    • Data Supplement - Appendix 1: Supplementary methods, tables, and figures
    • Data Supplement - Appendix 2: Details of additional consortium members, acknowledgements, and funding

Related articles

See more

Cited by...

  • Specificity of a polygenic score for aggressive prostate cancer
  • From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study
  • Genetics of prostate cancer: a review of latest evidence
  • Agent Orange exposure and prostate cancer risk in the Million Veteran Program
  • Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program
  • PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men
  • Genome-wide polygenic score with APOL1 risk genotypes predicts chronic kidney disease across major continental ancestries
  • Cancer Diagnosis, Polygenic Risk, and Longevity-Associated Variants
  • Precision Prostate Cancer Screening with a Polygenic Risk Score
  • The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation
  • Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review
  • A non-APOE Polygenic score for Alzheimers disease and APOE-{varepsilon}4 have independent associations with dementia in the Health and Retirement Study
  • Understanding polygenic models, their development and the potential application of polygenic scores in healthcare
  • Promises and perils of using genetic tests to predict risk of disease
  • Cancer Progress and Priorities: Prostate Cancer
  • Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers
  • Efficient estimation and applications of cross-validated genetic predictions
  • Sex-dependent polygenic effects on the clinical progressions of Alzheimers disease
  • PSA screening: Back to the future
  • Categorising severity of disease is inevitable and essential in routine medical practice
Back to top